BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 15106236)

  • 1. Non steroidal anti-inflammatory drugs (NSAID) and Aspirin for preventing colorectal adenomas and carcinomas.
    Asano TK; McLeod RS
    Cochrane Database Syst Rev; 2004; 2004(2):CD004079. PubMed ID: 15106236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoprevention of colorectal cancer: systematic review and economic evaluation.
    Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P
    Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonsteroidal anti-inflammatory drugs and aspirin for the prevention of colorectal adenomas and cancer: a systematic review.
    Asano TK; McLeod RS
    Dis Colon Rectum; 2004 May; 47(5):665-73. PubMed ID: 15054679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary fibre for the prevention of recurrent colorectal adenomas and carcinomas.
    Yao Y; Suo T; Andersson R; Cao Y; Wang C; Lu J; Chui E
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD003430. PubMed ID: 28064440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventive effects of low-dose aspirin on colorectal adenoma growth in patients with familial adenomatous polyposis: double-blind, randomized clinical trial.
    Ishikawa H; Wakabayashi K; Suzuki S; Mutoh M; Hirata K; Nakamura T; Takeyama I; Kawano A; Gondo N; Abe T; Tokudome S; Goto C; Matsuura N; Sakai T
    Cancer Med; 2013 Feb; 2(1):50-6. PubMed ID: 24133627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoprevention with low-dose aspirin, mesalazine, or both in patients with familial adenomatous polyposis without previous colectomy (J-FAPP Study IV): a multicentre, double-blind, randomised, two-by-two factorial design trial.
    Ishikawa H; Mutoh M; Sato Y; Doyama H; Tajika M; Tanaka S; Horimatsu T; Takeuchi Y; Kashida H; Tashiro J; Ezoe Y; Nakajima T; Ikematsu H; Hori S; Suzuki S; Otani T; Takayama T; Ohda Y; Mure K; Wakabayashi K; Sakai T
    Lancet Gastroenterol Hepatol; 2021 Jun; 6(6):474-481. PubMed ID: 33812492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Celecoxib as adjunctive therapy for treatment of colorectal cancer.
    North GL
    Ann Pharmacother; 2001 Dec; 35(12):1638-43. PubMed ID: 11793634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary fibre for the prevention of colorectal adenomas and carcinomas.
    Asano T; McLeod RS
    Cochrane Database Syst Rev; 2002; (2):CD003430. PubMed ID: 12076480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin and gastrointestinal cancer.
    Thun MJ
    Adv Exp Med Biol; 1997; 400A():395-402. PubMed ID: 9547582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics, inheritance and strategies for prevention in populations at high risk of colorectal cancer (CRC).
    Burn J; Mathers J; Bishop DT
    Recent Results Cancer Res; 2013; 191():157-83. PubMed ID: 22893205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.
    Sandler RS
    Important Adv Oncol; 1996; ():123-37. PubMed ID: 8791132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoprevention with special reference to inherited colorectal cancer.
    Lynch PM
    Fam Cancer; 2008; 7(1):59-64. PubMed ID: 17680350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Non-steroidal anti-inflammatory agents and prevention of colorectal adenomas and carcinomas].
    Raskov HH
    Ugeskr Laeger; 2006 Jan; 168(4):359-62. PubMed ID: 16436235
    [No Abstract]   [Full Text] [Related]  

  • 14. Non-steroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomas.
    Huls G; Koornstra JJ; Kleibeuker JH
    Lancet; 2003 Jul; 362(9379):230-2. PubMed ID: 12885487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical management of adenomatous polyposis in patients with hereditary non-polyposis colorectal cancer and familial adenomatous polyposis].
    Sheng JQ; Li SR; Yang XY; Zhang YH; Su H; Yu DL; Yan W; Geng HG
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):526-9. PubMed ID: 16681880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin and familial adenomatous polyposis: coming full circle.
    Chan AT
    Cancer Prev Res (Phila); 2011 May; 4(5):623-7. PubMed ID: 21543340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal cancer prevention: is an ounce of prevention worth a pound of cure?
    Gill S; Sinicrope FA
    Semin Oncol; 2005 Feb; 32(1):24-34. PubMed ID: 15726503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonsteroidal anti-inflammatory drugs, eicosanoids, and colorectal cancer prevention.
    DuBois RN; Giardiello FM; Smalley WE
    Gastroenterol Clin North Am; 1996 Dec; 25(4):773-91. PubMed ID: 8960892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal cancer chemoprevention: is this the future of colorectal cancer prevention?
    Manzano A; PĂ©rez-Segura P
    ScientificWorldJournal; 2012; 2012():327341. PubMed ID: 22649288
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.